These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 37835450)
1. DKK1 Promotes Epithelial-Mesenchymal Transition and Cisplatin Resistance in Gastric Cancer via Activation of the PI3K/AKT Pathway. Li J; Zhang Y; Ye F; Qian P; Qin Z; Li D; Ye L; Feng L Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835450 [TBL] [Abstract][Full Text] [Related]
2. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways. Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of FAM3B Promotes Cisplatin Resistance in Gastric Cancer by Inducing Epithelial-Mesenchymal Transition. Song C; Duan C Med Sci Monit; 2020 May; 26():e921002. PubMed ID: 32442162 [TBL] [Abstract][Full Text] [Related]
4. Dickkopf-related protein 1/cytoskeleton-associated protein 4 signaling activation by Luo M; Chen YJ; Xie Y; Wang QR; Xiang YN; Long NY; Yang WX; Zhao Y; Zhou JJ World J Gastroenterol; 2022 Dec; 28(47):6769-6787. PubMed ID: 36620343 [TBL] [Abstract][Full Text] [Related]
5. Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT. Tan J; You Y; Xu T; Yu P; Wu D; Deng H; Zhang Y; Bie P Toxicol Lett; 2014 Jan; 224(1):7-15. PubMed ID: 24144893 [TBL] [Abstract][Full Text] [Related]
6. Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis. Guo Q; Jing FJ; Xu W; Li X; Li X; Sun JL; Xing XM; Zhou CK; Jing FB Aging (Albany NY); 2019 Dec; 12(1):80-105. PubMed ID: 31895687 [TBL] [Abstract][Full Text] [Related]
7. The forkhead transcription factor FOXO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase/Akt pathway. Park J; Ko YS; Yoon J; Kim MA; Park JW; Kim WH; Choi Y; Kim JH; Cheon Y; Lee BL Gastric Cancer; 2014; 17(3):423-30. PubMed ID: 24202965 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer. Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223 [TBL] [Abstract][Full Text] [Related]
9. Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway. Yu M; Qi B; Xiaoxiang W; Xu J; Liu X Biomed Pharmacother; 2017 Jun; 90():677-685. PubMed ID: 28415048 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of AKT decreases the chemosensitivity of gastric cancer cells to cisplatin in vitro and in vivo. Zhang LL; Zhang J; Shen L; Xu XM; Yu HG Mol Med Rep; 2013 May; 7(5):1387-90. PubMed ID: 23546174 [TBL] [Abstract][Full Text] [Related]
11. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP). Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M Cell Physiol Biochem; 2016; 39(3):1098-110. PubMed ID: 27562816 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway. Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781 [TBL] [Abstract][Full Text] [Related]
13. PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells. Navaei ZN; Khalili-Tanha G; Zangouei AS; Abbaszadegan MR; Moghbeli M Oncol Res; 2021; 29(4):235-250. PubMed ID: 37303943 [TBL] [Abstract][Full Text] [Related]
14. Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K-AKT Pathway and Activating the AMPK-ROS Pathway. Wei X; Shi J; Lin Q; Ma X; Pang Y; Mao H; Li R; Lu W; Wang Y; Liu P Front Oncol; 2021; 11():642229. PubMed ID: 33816292 [No Abstract] [Full Text] [Related]
15. DKK1 promotes migration and invasion of non-small cell lung cancer via β-catenin signaling pathway. Zhang J; Zhang X; Zhao X; Jiang M; Gu M; Wang Z; Yue W Tumour Biol; 2017 Jul; 39(7):1010428317703820. PubMed ID: 28677426 [TBL] [Abstract][Full Text] [Related]
16. Salinomycin reduces epithelial-mesenchymal transition-mediated multidrug resistance by modifying long noncoding RNA HOTTIP expression in gastric cancer cells. Mao Z; Wu Y; Zhou J; Xing C Anticancer Drugs; 2019 Oct; 30(9):892-899. PubMed ID: 30882398 [TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway. Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766 [TBL] [Abstract][Full Text] [Related]
18. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties. Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998 [TBL] [Abstract][Full Text] [Related]
19. Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway. Wang H; Zhang G; Zhang H; Zhang F; Zhou B; Ning F; Wang HS; Cai SH; Du J Eur J Pharmacol; 2014 Jan; 723():156-66. PubMed ID: 24333218 [TBL] [Abstract][Full Text] [Related]
20. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation. Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]